Early safety study of MK-4482 in healthy men
NCT ID NCT06816030
First seen Apr 22, 2026 · Last updated May 23, 2026 · Updated 7 times
Summary
This study looked at how the drug MK-4482 is processed by the body and its safety in 16 healthy Chinese men. Participants took single and multiple doses of the drug. The goal was to measure drug levels in the blood and check for side effects. This is an early-stage study with no direct treatment benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking University Third Hospital (Site 0001)
Beijing, Beijing Municipality, 100191, China
Conditions
Explore the condition pages connected to this study.